11 Results for "

Factor VIIa

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "Factor VIIa" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-153480A
Purity:  93.65%
Synonyms: BAX499 sodium
ARC19499 sodium is an aptamer that inhibits tissue factor pathway inhibitor (TFPI) , thereby enabling clot initiation and propagation via the extrinsic pathway. The core aptamer binds tightly and specifically to TFPI. ARC19499 sodium blocks TFPI inhibition of both factor Xa and the TF/factor VIIa complex. ARC19499 sodium corrects thrombin generation in hemophilia A and B plasma and restores clotting in FVIII-neutralized whole blood.
loading...
    loading...
Cat. No.: HY-114511
CAS No.: 1004551-40-9
Purity:  99.90%
Target:  

Factor VIIa

Research Areas:  

Cardiovascular Disease

BMS-593214 is an active site-directed factor (F) VIIa inhibitor. BMS-593214 shows antithrombotic and antihaemostatic properties. BMS-593214 is a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of Viia-activated substrate FX. BMS-593214 prevents electroinduced carotid artery thrombosis (AT) and wire induced vena cava thrombosis (VT) .
loading...
    loading...
Cat. No.: HY-P5992
CAS No.: 161572-31-2
Target:  

Peptides

Research Areas:  

Others

Factor VIIa substrate is a colorimetric substrate for Factor VIIa, that can be measured by absorbance at 405 nm .
loading...
    loading...
Cat. No.: HY-153480
CAS No.: 1350667-54-7
Synonyms: BAX499
ARC19499 is an aptamer that inhibits tissue factor pathway inhibitor (TFPI) , thereby enabling clot initiation and propagation via the extrinsic pathway. The core aptamer binds tightly and specifically to TFPI. ARC19499 blocks TFPI inhibition of both factor Xa and the TF/factor VIIa complex. ARC19499 corrects thrombin generation in hemophilia A and B plasma and restores clotting in FVIII-neutralized whole blood.
loading...
    loading...
Cat. No.: HY-P3235
CAS No.: 1926163-13-4
Target:  

Factor VIIa

Research Areas:  

Others

E-76 is a peptide with anticoagulant activity. E-76 inhibits blood coagulation by specifically binding to exogenous coagulation factor VIIa (FVIIa). E-76 can be used to study blood coagulation-related diseases .
loading...
    loading...
Cat. No.: HY-172905
CAS No.: 885684-79-7
Target:  

Others

Research Areas:  

Cardiovascular Disease

BCX-3607 is an orally active tissue factor/factor VIIa (TF-FVIIa) inhibitor (IC50: 4 nM). BCX-3607 blocks the extrinsic coagulation pathway by inhibiting the TF-FVIIa complex and significantly prolongs the prothrombin time (PT). BCX-3607 has a higher selectivity for TF-FVIIa than other serine proteases (such as thrombin, FXa, etc.). BCX-3607 can reduce thrombus weight and inflammatory response, and has both anti-thrombotic and anti-inflammatory effects. BCX-3607 can be used in the study of thrombosis-related diseases .
loading...
    loading...
Cat. No.: HY-P991029
CAS No.: 2933972-64-4
Synonyms: HMB-001
Sutacimig (HMB-001) is a humanized antibody of the (H-γ4_L-κ)_(H-γ4_L-κ) format that targets FⅦa/TREML1. One arm of Sutacimig binds to endogenous FVIIa, thereby prolonging the half-life of FVIIa and increasing its accumulation in the bloodstream, while the other arm binds to TLT-1, which is exclusively expressed on the surface of activated platelets. This localizes endogenous FVIIa to activated platelets, further enhancing the activity of FVIIa. Sutacimig enhances Thrombin generation, fibrin formation, and the formation of stable fibrin-platelet networks at sites of vascular injury. Sutacimig can be used in studies related to Glanzmann thrombasthenia .
loading...
    loading...
Cat. No.: HY-E70541A
CAS No.: 9001-28-9
Research Areas:  

Cardiovascular Disease

Bovine Factor IX is prepared from freshly collected bovine plasma. Factor IX activated by the Factor VIIa/tissue factor/phospholipid complex is responsible for the activation of Factor X to Factor Xa .
loading...
    loading...
Cat. No.: HY-P70993
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Platelet-Activating Factor Acetylhydrolase; PAF Acetylhydrolase; 1-Alkyl-2-Acetylglycerophosphocholine Esterase; 2-Acetyl-1-Alkylglycerophosphocholine Esterase; Group-VIIa Phospholipase A2; gVIIa-PLA2; LDL-Associated Phospholipase A2; LDL-PLA(2); PAF 2-Acylhydrol
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700567
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PLA2G7; phospholipase A2, group VII (platelet-activating Factor acetylhydrolase, plasma); platelet-activating Factor acetylhydrolase; LDL PLA2; PAFAH; LDL-PLA(2); gVIIa-PLA2; PAF 2-acylhydrolase; PAF acetylhydrolase; group-VIIa phospholipase A2; LDL-associated phospholipase A2; lipoprotein-associated phospholipase A2; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; PAFAD; LP-PLA2; LDL-PLA2
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700568
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PLA2G7; phospholipase A2, group VII (platelet-activating Factor acetylhydrolase, plasma); platelet-activating Factor acetylhydrolase; LDL PLA2; PAFAH; LDL-PLA(2); gVIIa-PLA2; PAF 2-acylhydrolase; PAF acetylhydrolase; group-VIIa phospholipase A2; LDL-associated phospholipase A2; lipoprotein-associated phospholipase A2; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; PAFAD; LP-PLA2; LDL-PLA2;
Species:  
Source:  
loading...
    loading...
  • 1